Home › Agent Hub › Agent Tools › Part D coverage by drug › Simbrinza
Agent Tools
Simbrinza is a brand of brimonidine / brinzolamide. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2027, 4,493 of 5,492 Medicare Part D and Medicare Advantage drug plans (81.8%) list Simbrinza on their formulary, across 225 of 286 formularies. The most common placement is tier 4 (2,678 plans, 59.6% of those covering it). 8 of the covering plans require prior authorization (0.2%), 0 step therapy and 143 a quantity limit.
322 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $40, 76 of them $0; 4,171 charge coinsurance instead — median 25% of the drug's cost. Once a member's out-of-pocket drug spending reaches $2,400 in 2027, covered drugs cost $0 for the rest of the year.
2026: 4,494 of 5,496 plans covered it (81.8%); 2027: 4,493 of 5,492 (81.8%).
Of 4,367 plans offered in both years, 208 added it to the formulary and 91 dropped it.
Among plans covering it both years, 38 moved it to a higher tier and 16 to a lower one; 0 added prior authorization and 0 removed it.
| Tier | Plans |
|---|---|
| Tier 1 | 115 |
| Tier 2 | 8 |
| Tier 3 | 1,692 |
| Tier 4 | 2,678 |
| Plan type | Plans covering | Share | Prior auth |
|---|---|---|---|
| Stand-alone Part D (PDP) | 189 of 323 | 58.5% | 0% |
| Medicare Advantage with drugs (MA-PD) | 2,622 of 3,200 | 81.9% | 0.2% |
| Special needs plans (SNP) | 1,682 of 1,969 | 85.4% | 0.1% |
| Carrier | Plans covering | Usual tier | Prior auth |
|---|---|---|---|
| Humana | 846 of 846 | Tier 4 | 0 |
| UnitedHealthcare | 830 of 830 | Tier 3 | 0 |
| Devoted Health | 446 of 728 | Tier 4 | 0 |
| Aetna Medicare | 611 of 631 | Tier 4 | 0 |
| Wellcare | 0 of 268 | No tier listed | 0 |
| HealthSpring | 186 of 226 | Tier 4 | 0 |
| Kaiser Permanente | 0 of 112 | No tier listed | 0 |
| SCAN Health Plan | 83 of 83 | Tier 4 | 0 |
| Highmark Blue Cross Blue Shield or Highmark Blue Shield | 80 of 80 | Tier 4 | 0 |
| Alignment Health Plan | 77 of 77 | Tier 3 | 0 |
| Anthem Blue Cross and Blue Shield | 74 of 74 | Tier 3 | 0 |
| Wellpoint | 63 of 63 | Tier 3 | 0 |
| Priority Health Medicare | 40 of 40 | Tier 4 | 0 |
| CarePlus Health Plans, Inc. | 37 of 37 | Tier 4 | 0 |
| Zing Health | 36 of 36 | Tier 4 | 0 |
| Capital Blue Cross | 35 of 35 | Tier 4 | 0 |
| Prominence Health Plan | 29 of 29 | Tier 3 | 0 |
| Medica | 0 of 27 | No tier listed | 0 |
| Anthem HealthKeepers | 26 of 26 | Tier 3 | 0 |
| Blue Cross Blue Shield of Michigan | 26 of 26 | Tier 3 | 0 |
| State | Plans covering | Share |
|---|---|---|
| Alabama | 102 of 114 | 89.5% |
| Alaska | 5 of 9 | 55.6% |
| American Samoa | 1 of 1 | 100% |
| Arizona | 126 of 147 | 85.7% |
| Arkansas | 68 of 85 | 80% |
| California | 330 of 397 | 83.1% |
| Colorado | 84 of 106 | 79.2% |
| Connecticut | 41 of 54 | 75.9% |
| Delaware | 33 of 43 | 76.7% |
| District of Columbia | 8 of 12 | 66.7% |
| Florida | 421 of 545 | 77.2% |
| Georgia | 117 of 149 | 78.5% |
| Guam | 1 of 1 | 100% |
| Hawaii | 34 of 50 | 68% |
| Idaho | 38 of 45 | 84.4% |
| Illinois | 99 of 132 | 75% |
| Indiana | 117 of 138 | 84.8% |
| Iowa | 53 of 64 | 82.8% |
| Kansas | 70 of 84 | 83.3% |
| Kentucky | 103 of 121 | 85.1% |
| Louisiana | 91 of 125 | 72.8% |
| Maine | 45 of 52 | 86.5% |
| Maryland | 33 of 49 | 67.3% |
| Massachusetts | 86 of 89 | 96.6% |
| Michigan | 152 of 182 | 83.5% |
| Minnesota | 36 of 63 | 57.1% |
| Mississippi | 79 of 104 | 76% |
| Missouri | 139 of 170 | 81.8% |
| Montana | 23 of 27 | 85.2% |
| Nebraska | 36 of 51 | 70.6% |
| Nevada | 91 of 100 | 91% |
| New Hampshire | 19 of 25 | 76% |
| New Jersey | 61 of 73 | 83.6% |
| New Mexico | 57 of 68 | 83.8% |
| New York | 166 of 215 | 77.2% |
| North Carolina | 146 of 176 | 83% |
| North Dakota | 16 of 26 | 61.5% |
| Northern Mariana Islands | 1 of 1 | 100% |
| Ohio | 129 of 171 | 75.4% |
| Oklahoma | 71 of 81 | 87.7% |
| Oregon | 61 of 92 | 66.3% |
| Pennsylvania | 272 of 323 | 84.2% |
| Puerto Rico | 62 of 64 | 96.9% |
| Rhode Island | 21 of 29 | 72.4% |
| South Carolina | 77 of 89 | 86.5% |
| South Dakota | 18 of 30 | 60% |
| Tennessee | 142 of 156 | 91% |
| Texas | 359 of 407 | 88.2% |
| U.S. Virgin Islands | 1 of 1 | 100% |
| Utah | 47 of 53 | 88.7% |
| Vermont | 11 of 14 | 78.6% |
| Virginia | 123 of 144 | 85.4% |
| Washington | 80 of 114 | 70.2% |
| West Virginia | 62 of 69 | 89.9% |
| Wisconsin | 85 of 96 | 88.5% |
| Wyoming | 9 of 13 | 69.2% |
Medicare Part D paid for 463,366 30-day fills of Simbrinza in 2024 for about 74,513 enrollees, at an average total cost of $170.18 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price Simbrinza and the rest of a client's list on every plan in their county.
Estimate Simbrinza costs by plan
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.